Lee Jiyong, Reddy M Muralidhar, Kodadek Thomas
Division of Translational Research, Departments of Internal Medicine and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd. Dallas, TX 75390 (USA).
Departments of Chemistry & Cancer Biology, The Scripps Research Institute, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458 (USA). Tel: 561-228-2461.
Chem Sci. 2010 Jul;1(1). doi: 10.1039/C0SC00197J.
The orexin neurohormones control a variety of important physiological processes by signaling through two related G protein-coupled receptors, including appetite and feeding, wakefulness and energy homeostasis. Pharmacological manipulation of orexin signaling is an important goal. Here we describe the isolation of orexin receptor ligands from a library of microarray-displayed peptoids via a novel two-color, cell-based screen. Functional analysis of derivatives of these "hits" resulted in the development of moderate potency, low molecular weight receptor antagonists. Moreover, further optimization efforts resulted in the fortuitous discovery of a compound that positively potentiates the activity of the receptor. This compound is the first small molecule reported to up-regulate orexin signaling.
食欲素神经激素通过两种相关的G蛋白偶联受体发出信号,从而控制各种重要的生理过程,包括食欲与进食、觉醒和能量平衡。对食欲素信号进行药理学调控是一个重要目标。在此,我们描述了通过一种新型的基于细胞的双色筛选方法,从微阵列展示类肽文库中分离食欲素受体配体的过程。对这些“命中”化合物的衍生物进行功能分析,开发出了中等效力、低分子量的受体拮抗剂。此外,进一步的优化工作意外发现了一种能正向增强受体活性的化合物。该化合物是首个被报道可上调食欲素信号的小分子。